| 1 |
Krook JE,Moertel CG,Gunderson LL,et al.Effective surgical adjuvant therpay for high-risk rectal carcinoma.N Engl J Med,1991,324(11):709-715.
|
| 2 |
NIH Consensus Conference:Adjuvant therapy for patients with colon and rectal cancer.JAMA,1990,264(11):1444-1450.
|
| 3 |
Videtic GM,Fisher BJ,Perera FE,et al.Preoperative radiation with concurrent 5-fluorouracil continuous infusion for locally advanced unresectable rectal cancer.Int J Radiat Oncol Biol Phys,1998,42(2):319-324.
|
| 4 |
Wagman R,Minsky BD,Cohen AM,et al.Sphincter preservation with preoperative radiation therapy and coloanal anastomosis:Long term follow-up.Int J Radiat Oncol Biol Phys,1998,42(1):51-57.
|
| 5 |
Swedish Rectal Cancer Trial:Improved survival with preoperative radia-tion in resectable rectal cancer.N Engl J Med,1997,336(14):980-987.
|
| 6 |
Van de Velde CJH: Preoperative radiotherapy and TME-surgery for rectal cancer: Detailed analysis in relation to quality control in random ized trial.Proc ASCO,2002,21:127a.
|
| 7 |
Sauer R, Becker H, Hohenberger W, et al. Preoperative versus Postoperative Chemoradiotherapy for Rectal Cancer. N Engl J Med, 2004, 351(17):1731-1740.
|
| 8 |
Amenós MC, García MN, Ragué JM, et al. Preoperative radio- chemotherapy (RT-CT) in rectal cancer. Prospective study with postoperative RT-CT control group.Clin Transl Oncol,2007,9(3):183-191.
|
| 9 |
Dahlberg M, Glimelius B, Graf W, et al. Preoperative irradiation affects functional results after surgery for rectal cancer:results from a randomized study.Dis Colon Rectum,1998,41(5):543-551.
|
| 10 |
Minsky BD.Adjuvant therapy of rectal cancer.Semin Oncol,1999,26(5):540-544.
|
| 11 |
Gerard JP,Glynne-Jones R,Blackstock W,et al.Radiochemotherapy in rectal cancer:the role of oxaliplatin.Colorectal Dis,2003,5(3):29-35.
|
| 12 |
Minsky BD, Cohen AM, Kemeny N, et al. Enhancement of radiation induced downstaging of rectal cancer by fluorouracil and high-dose leucovorin chemotherapy.J Clin Oncol,1992,10(1):79-84.
|
| 13 |
Chan AK,Wong A,Jenken D,et al.Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.Int J Radiat Oncol Biol Phys,2005,61(3):665-677.
|
| 14 |
Klautke G,Feyerherd P,Ludwig K,et al.Intensified concurrent chem oradiotherapy with 5-fluorouracil and irinotecan as neoadjuvant treatmentinpatientswithlocallyadvancedrectalcancer.BritishJCancer,2005,92(7):1215-1220.
|
| 15 |
Osti MF,Valeriani M,Masoni L,et al.Neoadjuvant chemoradiaion for locally advanced carcinoma of the rectum.Tumori,2004,90(3):303-309.
|
| 16 |
Coco C,Valentini V,Manno A,et al.Long-term results after neoadjuvant radiochemotherapy for locally advanced resectable extraperitoneal rectal cancer.Dis Colon Rectum,2006,49(3):311-318.
|
| 17 |
Bosset JF,Calais G,Daban A,et al.Does the addition of chemotherapy to preoperative radiation increase acute toxicity in patients with rectalcancer:reportof22921EORTCphaseIIItrial.ProcASCO,2003,22:249(1179).
|
| 18 |
Paolie AD,Innocente R,Buonadonna A,et al.Neoadjuvant therapy of rectal cancer;new treatment perspectives.Tumori,2004,90(4):373-378.
|
| 19 |
Dunst J, Debus J, Rudat V, et al. Neoadjuvant capecitabine combined with standard radiotherapy in patients with locally advanced rectal cancer.Strahlenther Onkol,2008,184(9):450-456.
|
| 20 |
Rdel C,Grabenbauer GG,Papadopoulos T,et al.Phase I-II trial of capecitabine,oxaliplatin,and radiation for rectal cancer.J Clin Oncol,2003,21(16):3098-3104.
|
| 21 |
邱辉忠,林国乐.开普拓在直肠癌新辅助治疗中的应用.中华肿瘤杂志,2006,28(8):635-636.
|
| 22 |
Ciardiello F, Caputo R, Bianco R, et al. Antitumour effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1893(Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.Clin Cancer Res,2000,6(5):2053-2063.
|
| 23 |
Mauceri HJ, Hanna NN, Beckett MA, et al. Combined effects of angiostatin and ionizing radiation in antitumour therapy. Nature, 1998, 394(6690):287-291.
|
| 24 |
Nordlinger B, Sorbye H, Collette L, et al. Final results of the EORTC intergroup randomized phase III study 40983 [EPOC] evaluating the benefit of peri-operative FOLFOX4 chemotherapy for patients with potentially resectable colorectal cancer liver metastases.J Clin Oncol,ASCO Annual Meeting Proceedings,2007,25(18S):LBA 5.
|
| 25 |
Francois Y,Nemoz CJ,Baulieux J,et al.Influence of the interval between preoperative radiation therapy and surgery on downstaging and on the rate of sphincter-sparing surgery for rectal cancer:the Lyon R90-01 randomized trial.J Clinic Oncol,1999,17(8):2396.
|
| 26 |
Tulchinsky H, Shmueli E, Figer A, et al. An interval ＞7 weeks between neoadjuvant therapy and surgery improves pathologic complete response and disease-free survival in patients with locally advanced rectal cancer.Ann Surg Oncol,2008,15(10):2661-2667.
|
| 27 |
Janjan NA,Crane C,Feig BW,et al.Improved overall survival among responders to preoperative chemoradiation for locally advanced rectal cancer.Am J Clin Oncol,2001,24(2):107-112.
|
| 28 |
Das P,Skibber JM,Rodriguez-Bigas MA, et al. Clinical and pathologic predictors of locoregional recurrence, distant metastasis and overall survival in patients treated with chemoradiation and mesorectal excision for rectal cancer.Am J Clin Oncol,2006,29(3):219-224.
|
| 29 |
O'Neil BH,Tepper JE.Current options for the management of rectal cancer.Curr Treat Option Oncol,2007,8(5):331-338.
|
| 30 |
Habr-Gama A, Perez RO, Proscurshim I, et al. Absence of lymph nodes in the resected specimen after radical surgery for distal rectal cancer and neoadjuvant chemoradiation therapy:What does it Mean?Dis Colon Rectum,2008,51(3):277-283.
|
| 31 |
Adams DR, Blatchford GJ, Lin KM, et al. Use of preoperative ultrasound staging for treatment of rectal cancer. Dis Colon Rectum, 1999, 42(2):159-166.
|